MGAM2 and diabetes mellitus: This data description presents the bioactive compounds identified in the grains of little millets that act as ligands to inhibit the activity of the target proteins α-amylase and human maltase-glucoamylase and thus contribute to the treatment of metabolic disorders such as diabetes.